These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5058669)

  • 1. Delta-aminolaevulinic acid in acute porphyria.
    Shanley BC; Taljaard JJ; Deppe WM; Joubert SM
    S Afr Med J; 1972 Jan; 46(4):84. PubMed ID: 5058669
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute intermittent porphyria. A clinical, biochemical and family study.
    Kreimer-Birnbaum M; Mosovich LL; Bannerman RM
    J Med; 1971; 2(3):149-66. PubMed ID: 5289639
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of the porphyrin precursors delta-aminolaevulinic acid (ALA) and porphobilinogen (PBG) in the acute attack of porphyria.
    Kramer S; Becker D; Viljoen D
    S Afr Med J; 1973 Sep; 47(38):1735-8. PubMed ID: 4270402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience].
    Zawirska B; Kwiatkowska W; Nowojska A
    Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of bloodletting on the excretion of porphyrius and clelta aminolevulinic acid as well as the clinical picture of porphyria cutanea tarda].
    Broese I; Mattheus A
    Dermatol Monatsschr; 1977 Feb; 163(2):111-8. PubMed ID: 858437
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the biochemical pathogenesis of acute intermittent porphyria].
    Heilmeyer L
    Munch Med Wochenschr; 1969 Apr; 111(16):905-9. PubMed ID: 5819143
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of delta-aminolaevulinic acid and porphobilinogen in human erythrocytes in acute intermittent porphyria.
    Doss M
    Enzyme; 1973; 16(1):343-53. PubMed ID: 4791053
    [No Abstract]   [Full Text] [Related]  

  • 9. Porphyrin synthesis in drug induced hepatic porphyria.
    Rao MR; Padmanaban G; Sarma PS
    Biochem Pharmacol; 1971 Aug; 20(8):2001-7. PubMed ID: 5137957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excretion of gamma delta-dioxovalerianic acid and delta-aminolaevulinic acid in various disorders of haem synthess].
    Kissel HJ; Heilmeyer LM; Heilmeyer L
    Ger Med Mon; 1969 Aug; 14(8):405-7. PubMed ID: 5349669
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic delta-aminolaevulinic acid synthetase activity in symptomatic porphyria.
    Zail SS; Joubert SM
    Br J Haematol; 1968 Aug; 15(2):123-9. PubMed ID: 5675527
    [No Abstract]   [Full Text] [Related]  

  • 12. The incorporation of [4-14C] delta-aminolaevulic acid into urinary porphyrins in symptomatic porphyria.
    Goldswain P; Dowdle E; Spong N; Eales L
    Clin Sci; 1970 Aug; 39(2):159-68. PubMed ID: 5473578
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute intermittent porphyria.
    Day RS; Eales L
    S Afr Med J; 1982 Feb; 61(8):260-1. PubMed ID: 7058452
    [No Abstract]   [Full Text] [Related]  

  • 14. Porphyria. Case presentations. Case 1: S.V.T., white female, 26 years.
    Eales L
    S Afr Med J; 1971 Sep; ():238-9. PubMed ID: 5150287
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of substrates for glycine acyltransferase, and the role of sulfanilamide and acetate in the reversal of chemically-induced porphyria in the rat.
    Tephly TR; Condie LW; Piper WN
    Enzyme; 1973; 16(1):187-95. PubMed ID: 4791042
    [No Abstract]   [Full Text] [Related]  

  • 16. A neurological disorder in porphyria cutanea tarda.
    Asmal AC; Vinik AI; Joubert SM
    S Afr Med J; 1970 Jul; 44(27):781-4. PubMed ID: 4317550
    [No Abstract]   [Full Text] [Related]  

  • 17. Porphyria. Case presentations. Case 3: M.A., non-white female, 26 years.
    Gordon W
    S Afr Med J; 1971 Sep; ():240. PubMed ID: 5150289
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary aldosteronism associated with acute intermittent porphyria. Report of a case.
    Basiliere J; Newcomer AD
    N Engl J Med; 1971 Sep; 285(11):595-8. PubMed ID: 5563960
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycine loading test in acute intermittent porphyria patients and their relatives.
    Loriaux DL; Deleña S; Brown H
    Metabolism; 1969 Oct; 18(10):860-6. PubMed ID: 5823743
    [No Abstract]   [Full Text] [Related]  

  • 20. Delta-aminolaevulinic acid in acute porphyria.
    Eales L
    S Afr Med J; 1972 May; 46(19):595. PubMed ID: 5076897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.